Rapamycin Longevity Lab is proud to announce that the world-leading researcher Brian Kennedy (@BKennedy_aging) will join the lab as a scientific advisor. We are also thrilled to welcome Kamil Pabis (@Aging_Scientist), a great researcher from Brian’s lab, who will take on the role of scientific lead at Rapamycin Longevity Lab. Together, we will evaluate and explore the opportunities of using @pumpdotscience as a platform to accelerate and fund longevity research in a new way. Now in mid September we are launching three promising longevity interventions on the platform. More details about this will be shared in the coming week. A very warm welcome to Brian and Kamil! We look forward to pushing the boundaries of longevity science together!
.@BKennedy_aging is one of the top longevity scientists in the world
to have his vote of confidence is groundbreaking for DeSci
huge congrats to @KristerKauppi@OMIPALRLL@Aging_Scientist
thank you for your trust
together we will develop the aging therapies that are so desperately needed
A new major milestone in the Omipalisib ($OMIPAL) journey has just been reached! We're thrilled to announce a partnership with @BioProtocol made possible by @pumpdotscience.
The OMI/BIO liquidity pool is now live!
Pool: OMI/BIO
Location: Raydium CLMM
Pool ID: CFFQHJQZd7SatSRLiGD1ehVaHsxpesNqyeSXBLyLh9cy
Current TVL: $10,965
This step is designed to:
1⃣ Deepen liquidity for $OMIPAL
2⃣ Align with the @BioProtocol ecosystem through shared AMM incentives
3⃣ Strengthen DeSci market infrastructure
Omipalisib is just getting started!
Wow, we did it! Another major milestone in the Omipalisib journey! We’ve claimed the king throne on @pumpdotscience! This means Omipalisib ($OMIPAL) now holds the record for the most effective lifespan extension in worms among all tested interventions on the platform.
We achieved a 37.5% increase in median lifespan which is on the lower end compared to previous observations. However, this is likely due to a long-lived control group in this experiment. If we normalize the control lifespan to match that of the previous record-holder Rapamycin, where the control lived 20 days instead of 21.8, then Omipalisib’s median lifespan effect would be 49.5% and more in line with our earlier results. The best lifespan extension ever recorded in worms by the Rapamycin Longevity Lab (@OMIPALRLL) stands at 63%.
But all this is a huge step forward. Next up is experiments in flies and based on some prior studies we’re optimistic. A massive thank you to everyone who’s supported us! This achievement wouldn’t be possible without you. Let’s keep pushing the boundaries of longevity science together. Omipalisib is just getting started!
I personally think #Tek is a great project and can catch hype easily. The term #Tek is widely used in crypto.
Token is very undervalued at 80mcap
Ca: 3APCa7KFSm6wVo74P7STRfG6zM5ehVwdshg5XYUubonk
Always Dyor